奥美拉唑结合康复新液治疗慢性萎缩性胃炎的药效评价  被引量:7

Observation of effect of omeprazole combined with Kangfuxin Ye on chronic atrophic gastritis

在线阅读下载全文

作  者:张红艳[1] 赵钰敏[1] 王雪[1] ZHANG Hong-yan ZHAO Yu-min WANG Xue(Henan Province People's Hospital, Zhengzhou, 450003, Chin)

机构地区:[1]河南省人民医院

出  处:《山西中医》2017年第6期23-24,43,共3页Shanxi Journal of Traditional Chinese Medicine

摘  要:目的:观察奥美拉唑结合康复新液治疗慢性萎缩性胃炎(CAG)的临床疗效。方法:将70例CAG患者随机分为西药组和中西药组,每组各35例。西药组给予奥美拉唑治疗,中西医结合组同时给予奥美拉唑合康复新液治疗,疗程均为6周。观察患者治疗前后临床疗效和血清环氧酶-1(COX-1)含量的变化。结果:西药组脱落3例,中西药组脱落1例。观察组总有效率为94.12%(95%CI=80.12%~99.24%),对照组为78.13%(95%CI=63.81%~92.45%),两组综合疗效比较(u=2.241 9,P=0.025 4),差异有显著性意义;与对照组比较,观察组可明显升高患者的COX-1参数(P<0.05);缩短显效时间(P﹤0.05)。结论 :采用奥美拉唑合康复新液治疗脾胃虚弱型CAG的疗效优于单纯应用奥美拉唑,其收益为OR=0.22(95%CI=0.04~1.17),NNT=6(95%CI=3.07~181.69)。且未见明显不良反应。Objective: To observe the clinical effect of omeprazole combined with Kangfuxin Liquid on chronic atrophic gastritis (CAG) . Methods: 70 cases of patients with CAG were randomly divided into treatment group and control group , 35 cases in each group.The treatment group was treated with omeprazole combined with Kangfuxin Ye, while the control group was treated with omeprazole, and the course of treatment was 6 weeks.The clinical effect and the content change of serum cyclooxygenase-1 (COX-1) of patients before and after treatment were observed. Results: The control group shed 3 cases, while the treatment group shed 1 case. The total effective rate of treatment group was 94.12% (95% CI = 80.12% to 99.24%) , while the total effective rate of control group was 78.13% (95% CI = 63.81% to 92.45%) . Compared the comprehensive effect between two groups (u= 2.241 9, P = 0.025 4) , the difference was statistically significant.Compared with the control group, the treatment group could significantly raise COX-1 parameter of patient (P〈0.05) , and shorten the effective time (P 〈0.05) . Conclusion: The clinical effect of omeprazole combined with Kangfuxin Ye on CAG of?spleen-stomach deficiency is better than that of simple omeprazole. Its benefit is OR = 0.22 (95% CI = 0.04 to 1.17) , NNT = 6 (95% CI = 3.07 to 181.69) . There is no obvious adverse reaction.

关 键 词:慢性萎缩性胃炎 奥美拉唑 康复新液 

分 类 号:R969.4[医药卫生—药理学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象